A Simple Key For Healthcare News Unveiled
Novo CEO pressed by Senate to cut costs of obesity, diabetic issues drugs CEO Lars Fruergaard Jørgensen instructed lawmakers the corporation would think about new talks with insurers about the listing rates of Wegovy and copyright if they pledge to help keep the medicines on their formularies.This plan aligns with those initiatives, the ONC said.